CJC no DAC
Compliance & Safety Protocol
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN USE.
Research Profile
What is CJC-1295 NO DAC?
CJC-1295 without DAC (Drug Affinity Complex), also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH). With the molecular formula C₁₅₂H₂₅₂N₄₄O₄₂ and a molecular weight of 3367.9 g/mol (CAS: 863288-34-0), this peptide represents the first 29 amino acids of GHRH with modifications at positions 2 (D-Ala), 8 (Ala), 15 (Gln), 16 (Leu), 23 (Tyr), 24 (Gln), and 28 (Ser).
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Ala-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-SerSpecifications
| CAS Number | 446036-97-1 |
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | 3367.9 g/mol |
| Purity | ≥99.0% (HPLC verified) |
| Form | Lyophilized powder |
| Storage | -20 °C, lyophilized |
| Shipping | Insulated packaging |
Mechanism of Action
GHRH Receptor
cAMP/PKA signalingCJC-1295 NO DAC binds to GHRH receptors on pituitary somatotrophs, activating adenylate cyclase and increasing intracellular cAMP in cell culture.
Growth Hormone Release
Intracellular calcium mobilizationThe peptide triggers intracellular calcium release and growth hormone secretion through GHRH receptor activation.
Storage & Handling
Related Compounds
Research Use Only
All compounds are sold strictly for laboratory research use. Not for human or animal consumption. These products are not drugs, supplements, or food. Statements have not been evaluated by the FDA. Must be 21+ to purchase. This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.
Ancillary Compounds
Scientific Context